HEATHER BROTT: Open Payments
NPI 1114484474 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$144 in 8 payments from 6 companies in 2025. Trend: 2023 $237 · 2024 $98 · 2025 $144
Food & beverage: $144
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Dexcom, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
Products named: Dexcom G6 Transmitter, Ozempic, Jornay PM, ZEPBOUND, VRAYLAR, Wegovy, ABILIFY ASIMTUFII, REXULTI.
Industry payments across IN — which companies pay providers there.
